Abstract
There have been promising results from clinical trials on the efficacy of engineering patients' immune cells to treat their cancers. CAR T-cell therapy also has unique toxicities advanced practitioners should be aware of.
CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
Volume 8, Number 3 (Apr 2017)
https://doi.org/10.6004/jadpro.2017.8.3.3
